This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jw Pharmaceutical Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Suha Park: Pharmaceutical Patent Inventor
Introduction
Suha Park is an inventor based in Seoul, South Korea, associated with J.W. Pharmaceutical Corporation. His patent work concerns a crystalline form of a pharmaceutical compound and its potential therapeutic applications.
Latest Patents
Park is named on 1 patent: “Crystalline Form of 1-(8-Bromopyrido[2,3-E][1,2,4]Triazolo[4,3-a]Pyrazin-4-Yl)-N-Methylazetidin-3-Amine Hydrogen Sulfate Monohydrate.” The patent describes a novel polymorph of the compound and pharmaceutical compositions containing it. It also discloses potential use in treating atopic dermatitis, itch, pruritus, and forms of urticaria, including chronic idiopathic urticaria subtypes.
Career Highlights
Park’s listed patent connects his work with pharmaceutical research and the development of crystalline forms of compounds intended for therapeutic use. He is associated with J.W. Pharmaceutical Corporation.
Collaborations
Park’s listed coworker is Seiho Chin, a woman. The available information identifies her as a coworker but does not specify her role in the patent.
Conclusion
Suha Park’s patent activity centers on a novel pharmaceutical polymorph and its potential applications in treating dermatological conditions and urticaria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile